Kari Furu, PhD
Kari Furu, PhD, is a passionate and solution oriented molecular biologist with broad experience in development and optimization of laboratory techniques and molecular assays. After completing her PhD and a postdoctoral fellowship in basic and cancer research, she made the transition to the biotech industry where her main focus has been in development of IVD assays. Kari joined Genetic Analysis, a Norwegian molecular diagnostic company with core focus on the microbiome, in 2016. She started as Development Manager before stepping up as the company’s’ Chief Technology Officer in 2021. With Genetic Analysis, Kari has managed multiple product development projects through cross-functional team leadership, including product design improvement projects aiming to increase robustness and cost-effectiveness of the company’s’ main product, the GA-map® Dysbiosis Test. She is experienced in design, production, installation, and servicing of IVD products in accordance with Design Control principles and ISO 13485. Together with the GA team, she is devoted to increase awareness of the microbiome and its impact on human health, as well as to the development of new diagnostic solutions based on microbiome profiling. Furthermore, as member of the management team in Genetic Analysis, Kari is dedicated to build strong teams and a fun and inspirational work environment.